Table 1. Baseline characteristics of the study participants. Values are means (±SE) or counts (%).

	DHA (n=14)	Placebo (n=13)	Between-group P-value
Age, yr	31.9 (3.1)	33.3 (2.4	.73
Height, m	1.63 (.02)	1.68 (.01)	.07
Weight, kg	60.3 (2.8)	66.1 (4.8)	.30
BMI, kg·m-2	22.7 (1.1)	23.5 (1.6)	.67
1RM, kg	6.1 (.3)	6.5 (.4)	.39
120% 1RM, kg	7.3 (.4)	7.8 (.4)	.39
Active participation in strength training, number of subjects	0 (0%)	0 (0%)	1.00
Active participation in endurance exercise training, number of subjects	5 (36%)	2 (15%)	.24
*Frequency endurance exercise, sessions/week	3(2)	3(2)	.54
Pill Compliance (%)	94 (2.7)	95 (1.9)	.84

BMI, body mass index; 1RM, one repetition maximum. Between-group p-values are from independent t-tests for quantitative data or Fisher’s exact tests for frequencies.